Yubo International Biotech LtdOTCQB:YBGJ
- LAST PRICE0.2100
- TODAY'S CHANGE (%)-0.7400 (-77.8947%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.5900 / 0.9500
- Day Range
- 52 Week Range
- Volume1,426,144
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | YBGJ |
|---|---|---|
| 09:54 ET | 1000 | 0.59 |
| 09:56 ET | 1000 | 0.59 |
| 10:01 ET | 3500 | 0.50815 |
| 10:17 ET | 100 | 0.51 |
| 10:26 ET | 3500 | 0.252 |
| 10:28 ET | 19921 | 0.11 |
| 10:30 ET | 50000 | 0.11 |
| 10:32 ET | 5850 | 0.11 |
| 10:33 ET | 106929 | 0.1125 |
| 10:35 ET | 100000 | 0.12 |
| 10:37 ET | 1800 | 0.1445 |
| 10:39 ET | 2000 | 0.119 |
| 10:42 ET | 100000 | 0.12105 |
| 10:44 ET | 93600 | 0.121 |
| 10:46 ET | 100000 | 0.117 |
| 10:48 ET | 60000 | 0.116 |
| 10:50 ET | 100000 | 0.117 |
| 10:51 ET | 80000 | 0.117 |
| 10:53 ET | 100000 | 0.118 |
| 10:55 ET | 70000 | 0.121 |
| 10:57 ET | 120000 | 0.121 |
| 11:00 ET | 68700 | 0.1382 |
| 11:02 ET | 40291 | 0.136 |
| 11:06 ET | 49909 | 0.138 |
| 11:09 ET | 45000 | 0.138 |
| 11:11 ET | 1500 | 0.1381 |
| 11:36 ET | 10000 | 0.1989 |
| 11:38 ET | 29000 | 0.2 |
| 11:40 ET | 5250 | 0.2769 |
| 11:42 ET | 5500 | 0.2869 |
| 11:44 ET | 12500 | 0.388 |
| 11:45 ET | 14000 | 0.389 |
| 11:47 ET | 10000 | 0.3132 |
| 11:51 ET | 2100 | 0.288 |
| 11:54 ET | 4690 | 0.2999 |
| 12:03 ET | 500 | 0.3 |
| 02:15 ET | 225 | 0.22757 |
| 03:45 ET | 7100 | 0.21 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Yubo International Biotech Ltd | 25.2M | -21.0x | --- |
Oncternal Therapeutics Inc | 24.5M | -0.6x | --- |
Aprea Therapeutics Inc | 28.2M | -1.3x | --- |
UNITY Biotechnology Inc | 25.2M | -0.5x | --- |
Sensei Biotherapeutics Inc | 25.6M | -0.8x | --- |
Forte Biosciences Inc | 26.1M | -0.6x | --- |
Company Information
Yubo International Biotech Ltd, formerly Magna-Lab Inc, is a holding company primarily operating through its subsidiary. The Company focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The Company also offers stem cell related services including cell testing and health management consulting services.
Contact Information
- Headquarters
- Room 105, Building 5, 31 Xishiku AvenueBEIJING, BEJ, China 00000
- Phone
- 106-615-5141
- Fax
- 516-595-1159
Executives
- President, Chief Executive Officer, Director
- Jun Wang
- Chief Financial Officer, Treasurer, Company Secretary, Director
- Lina Liu
- Director
- Yang Wang
- Independent Director
- Zhihui Bai
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $25.2M |
|---|---|
Revenue (TTM) | $604.7K |
Shares Outstanding | 119.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.53 |
EPS | $-0.01 |
Book Value | $-0.02 |
P/E Ratio | -21.0x |
Price/Sales (TTM) | 41.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -197.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
